Showing results (1141-1150 of 4,879) with videos related to
Sort By:
Pageof 488
Urologic Oncology|August 17, 2026
Intravesical recurrence is associated with increased Treg and exhausted CD8+ T cells in upper tract urothelial carcinomaDaisuke Ito, Tokiyoshi Tanegashima, Genshiro Fukuchi, et al.Urologic Oncology|September 11, 2026
Cryoablation for localized prostate cancer: Feasibility in large prostatesJamie Michael, Kathryn Fink, Vivian Wan, et al.Urologic Oncology|September 12, 2026
Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tankPavlos Msaouel, Salvatore La Rosa, Edwin Jason Abel, et al.Urologic Oncology|September 14, 2026
CDKL1 facilitates tumorigenesis and metastasis of bladder urothelial carcinoma by activating SIRT1/Wnt/β-catenin signalingHuajun Tan, Yun Zhang, Yongqi Long, et al.Urologic Oncology|September 18, 2026
FOCS-24: An integrated oncologic-functional endpoint and its preoperative nomogram after focal therapy for localized prostate cancerUmberto Anceschi, Salvatore Basile, Leonardo Misuraca, et al.Urologic Oncology|September 18, 2026
Diagnostic value of CEUS-VI-RADS for predicting muscle invasion in bladder cancer: Validation of the scoring system and introduction of tumor-bladder wall contact length as a supplementary quantitative metricWenhao Qu, Ju Zhu, Yahan Yang, et al.Urologic Oncology|September 18, 2026
Risk of androgen deprivation therapy after active surveillance for prostate cancer: A real-world analysisJames R Janopaul-Naylor, Dattatraya Patil, Nikhil T Sebastian, et al.Urologic Oncology|June 18, 2003
Is bladder biopsy necessary at three or six months post BCG therapy?Ralph A Highshaw, Stacy T Tanaka, Christopher P Evans, et al.Urologic Oncology|June 18, 2003
Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisionsCaleb P Nelson, Rodney L Dunn, John T Wei, et al.Urologic Oncology|June 18, 2003
Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpointsWilliam K OhPageof 488